To meet patient expectations and be economically sustainable, the healthcare industry needs to break information silos and leverage all the opportunities offered by technology. In this post, Silvia Piai, EMEA Senior Research Manager – IDC Health Insights, offers an interesting perspective on the need and the opportunity for a stronger convergence between Healthcare and Life Sciences.
Silvia Piai, EMEA Senior Research Manager – IDC Health Insights
In the last few months, I have had an increasing number of conversations with research hospitals and other clinical research institutions about the opportunities offered to medical research by the growing availability of health information in a number of digital formats. Having potential access to an expanding variety of health information is driving university hospitals, and other research institutions, to rethink the organization of their processes and information systems. Collaborating with the broader healthcare ecosystems, leveraging the health data convergence between healthcare providers, public health authorities and healthcare national payers is a key priority.
This emerged not only during the conversations I personally had with different European research executives, but also from the insights of a recent IDC Health Insights European study, sponsored by EMC, analyzing the expectations, the current barriers and investment plans of top European university hospitals and clinical research institutions.
Leveraging health data convergence is essential to what more than 80% of clinical research organizations interviewed consider high priority:
- Enabling better integration and continuity between patient care delivery & research
- Improve efficiency in research and clinical trial processes
- Improve performance, success rate and recognition as center of excellence for research
These objectives can be achieved only if their organizations have access to real world evidence, and will be supported by a closed loop feedback fostered by safer and smarter patient information sharing systems, allowing data to be securely analyzed and reused in
different contexts and for different purposes.
Advances in new fields as personalized medicine, n-of-1 clinical trials, and translational medicine see in this convergence the ideal platform allowing a broader and more complex interplay of patients’ health determinants and shortening the “bench-to-bedside” timeframe. However, Continue reading